There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| 1 | 2 | 1938.4 |
| 1 | 1 | 1938.1 |
| 1 | 2 | 1937.8 |
| 1 | 2 | 1937.7 |
| 1 | 5 | 1937.6 |
| Ask | Qty | Orders |
|---|---|---|
| 1939.5 | 1 | 9 |
| 1939.6 | 3 | 13 |
| 1939.7 | 1 | 1 |
| 1939.8 | 3 | 43 |
| 1939.9 | 5 | 44 |
Our researchers has found no immediate positive insights for this stock. We'll update this space as soon as we find something.
Narayana Hrudayalaya Limited (Narayana Health) is an Indian healthcare services company incorporated in 2000, operating multi-specialty hospitals, heart centres, clinics and dialysis facilities across India and overseas. Its core offerings include hospital care services delivered through a network model, and the sale of medical consumables and drugs within its ecosystem . The Company’s footprint spans 11 States in India—across the Western (Ahmedabad, Mumbai), Karnataka (Bengaluru, Mysore, Davangere, Dharwad, Kolar, Shimoga), Eastern (Guwahati, Jamshedpur, Kolkata, Raipur) and Northern (Jaipur, Delhi, Gurugram, Katra) regions—along with two owned and operated hospitals in the Cayman Islands . As on March 31, 2025, the Company had 19 owned/operated hospitals, 2 heart centres and 18 clinics and dialysis centres in India, reflecting an end-to-end presence from preventive to complex tertiary care . The Group comprised 15 subsidiaries and 1 associate company as at March 31, 2025 .
Narayana Health has recorded notable clinical milestones, including Karnataka’s first ankle replacement and India’s first knee replacement using the smallest 3D-printed patient-specific implant. It also performed a pioneering radiofrequency ablation for a foetus with congenital heart disease at 22 weeks’ gestation, enabling full-term delivery . In cardiac sciences, its teams conducted 35,000+ diagnostics, 18,500+ interventions, 16,500+ surgeries, and 5,000+ electrophysiology procedures, with 300+ robotic cardiac surgeries at Narayana Institute of Cardiac Sciences, Narayana Health City, and crossed 5,000 cumulative cardiac surgeries at Narayana Hospital Howrah . Neurosciences achievements included Rajasthan’s first Deep Brain Stimulation, a rare mechanical thrombectomy on an ECMO-supported patient at R N Tagore, and more than 100 epilepsy surgeries at SRCC Children’s Hospital, Mumbai; oncology and orthopaedics saw 8,500+ and 13,000+ surgeries respectively .
– By activity: Hospital and Medical Care (Health Care Services) accounted for 95.88 Per cent of turnover; Sale of Medical Consumables & Drugs contributed 3.04 Per cent .
– By geography: Exports contributed 1.08 Per cent of the entity’s total turnover .
– Dr. Devi Prasad Shetty – Chairman .
– Dr. Emmanuel Rupert – Managing Director and Group CEO .
– Mr. Viren Prasad Shetty – Executive Vice Chairman .
– Ms. Sandhya Jayaraman – Chief Financial Officer .
– Mr. Sridhar S – Group Company Secretary, Legal and Compliance Officer .
– The Company received an [ICRA] AA (Stable) credit rating on January 20, 2025 for its privately placed Non-Convertible Debentures, reflecting a high degree of safety in servicing obligations .
– During the year, its unsecured, rated, listed, redeemable Non-Convertible Debentures were listed on BSE; ISINs for the debt are INE410P08016 (Rs 300 crore) and INE410P08024 (Rs 500 crore) .
– Health City Cayman Islands expanded capacity with a new facility at Camana Bay, supporting growth in Cayman operations .
– Dr. Emmanuel Rupert was re-appointed as Managing Director and Group CEO for three years, effective February 11, 2025 to February 10, 2028 .
– Narayana Health Insurance Limited, a wholly-owned subsidiary, received an IRDAI licence on January 3, 2024 and commenced operations on June 16, 2024, marking the Group’s entry into health insurance .
– The Company has outlined a Rs 3,000 crore capital expenditure plan across key geographies to strengthen capacity and access .
– The Integrated Care segment scaled to 10 clinics in Bengaluru with growing patient adoption and operating revenue momentum .
For Q4 FY26, Narayana Hrudayalaya Ltd reported: Revenue (Net Sales): ₹10440.50 Cr - Up 7.77% year-on-year from ₹9687.81 Cr in Q3 FY26. Net Income (PAT): ₹2021.25 Cr - Up 166.88% year-on-year from ₹757.37 Cr in Q3 FY26.
The intraday high for Narayana Hrudayalaya Ltd on the NSE today (04 Jul 2026) was ₹2,049.50. This compares to the 52-week high of ₹2,093.30 recorded on 17 Nov 2025. Today's high was -2.09% below the 52-week high.
Narayana Hrudayalaya Ltd has delivered a return of 18.80% over the last 3 months. The stock was trading at ₹1,685.90 on 06 Apr 2026 and is currently at ₹2,002.80 as of 04 Jul 2026, reflecting a Gain of ₹316.90 per share over this period.
Narayana Hrudayalaya Ltd has delivered -0.43% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹2,093.30 on 17 Nov 2025 and a 52-week low of ₹1,589.00 on 02 Apr 2026. It is currently trading at ₹2,002.80 as of 04 Jul 2026.
The all-time high (ATH) for Narayana Hrudayalaya Ltd was ₹2,263.20, recorded on 27 Jun 2025. At the current price of ₹2,002.80, the stock is trading 11.51% below its all-time high. The all-time low recorded was ₹185.95 on 30 Jan 2019.
Narayana Hrudayalaya Ltd has delivered a 323.34% absolute return over the past 5 years, equivalent to a CAGR of 33.46% per annum. The stock was priced at ₹473.09 in Jul 2021 and has risen to ₹2,002.80 as of 04 Jul 2026. An investment of ₹1,00,000 in Narayana Hrudayalaya Ltd five years ago would be worth ₹4,23,340.00 today.
Yes,Narayana Hrudayalaya Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 16.50 per share between FY2022 and FY2026, with the most recent dividend of ₹4.50 per share for May 26, with an ex-dividend date of 17 Jul 2026. At the current market price of ₹2,002.80, the trailing dividend yield of Narayana Hrudayalaya Ltd stands at 8.50%.
Over the last 6 months, Narayana Hrudayalaya Ltd has given a return of 5.34%. The stock was priced at ₹1,901.20 on 05 Jan 2026 and has Rise to ₹2,002.80 as of 04 Jul 2026, a change of ₹101.60 per share.
As of 04 Jul 2026, the share price of Narayana Hrudayalaya Ltd is ₹2,002.80 on the NSE and ₹1,999.95 on the BSE. The stock opened at ₹1,986.20, touched a high of ₹2,049.50 and a low of ₹1,953.50 during today's session.
The intraday low for Narayana Hrudayalaya Ltd on the NSE today was ₹1,953.50. The stock's 52-week low stands at ₹1,589.00, recorded on 02 Apr 2026. Today's low is 22.94% above the 52-week low, indicating the stock is trading well above its yearly lows.
